Effect of Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes: A Randomized 3-month Clinical Trial Using a Sequential Parallel Comparison Design
Latest Information Update: 06 Mar 2023
At a glance
- Drugs Suvorexant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
Most Recent Events
- 03 Feb 2023 Status changed from active, no longer recruiting to completed.
- 31 Aug 2021 Status changed from recruiting to active, no longer recruiting.
- 03 May 2021 Planned primary completion date changed from 15 Mar 2021 to 15 Sep 2021.